Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran

Alireza Noroozi; Katherine M. Conigrave; Bahareh MirrahimiParsa BastaniNader CharkhgardMohammad SalehiHooman NarenjihaAlaleh VaziriAbbas Kebriaeezadeh

首页> 外文期刊>Drug and alcohol review >Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran

【24h】

Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran

机译：Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Abstract Introduction In response to a high burden of opioid use disorder (OUD), Iran established a network of opioid agonist treatment (OAT) centres beginning in 2002. To increase treatment diversity, particularly for patients who use opium as their drug of choice, opium tincture (OT)‐assisted treatment was introduced to the network. This study aimed to explore factors influencing OT‐assisted treatment selection for OUD in Tehran, Iran. Methods We conducted 54 in‐depth interviews with patients with OUD (n?=?33), family members of patients (n?=?9) and drug treatment providers (n?=?12). Participants were recruited from 12 drug treatment centres across Tehran, between September and November 2019. All interviews were audio‐recorded, transcribed and coded in OpenCode 4.02 software and analysed using thematic analysis. Results Study participants more commonly reported individual‐level factors as facilitators (e.g. to reduce harms associated with illicit opioid use, achieve recovery through a gradual dose reduction regimen combined with Congress 60 recovery program) and structural level factors (e.g. low adoption by OAT system and lack of familiarity of treatment providers) as barriers for utilisation of OT‐assisted treatment regimens. OT was perceived to produce lower levels of physiological dependence than methadone, but the requirement for twice supervised dosing was restrictive. Low familial and community acceptance were also seen as barriers to access. Discussion and Conclusions This research identified a range of perceived benefits for OT‐assisted treatment ranging from harm reduction to an intermediate step to achieve recovery. However, several structural‐, individual‐, familial‐ and community‐level barriers impede its availability and acceptability.

著录项

来源
《Drug and alcohol review》 |2022年第2期|419-429|共11页
作者
Alireza Noroozi; Katherine M. Conigrave; Bahareh MirrahimiParsa BastaniNader CharkhgardMohammad SalehiHooman NarenjihaAlaleh VaziriAbbas Kebriaeezadeh;
展开▼
作者单位

Iranian National Center for Addiction Studies,Tehran University of Medical Sciences;

Addiction Medicine, Sydney School of Medicine (Central Clinical School),The University of Sydney;

Department of Pharmacoeconomics and Pharmaceutical Management, School of Pharmacy,Tehran UniversityDepartment of Anthropology,Brown UniversitySubstance Abuse and Dependence Research Center,University of Social Welfare and Rehabilitation;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类药学;
关键词
opioid use disorder; opium tincture; treatment; qualitative study; barriers;

Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran

摘要

著录项

相关主题

期刊订阅